Findings from a study in the journal JAMA Oncology showed immunotherapy's potential as a treatment for the HIV-associated cancer Kaposi's sarcoma in HIV-positive patients. Data indicated a 67% response rate when checkpoint inhibitors were given to the patients.
Study finds immunotherapy beneficial in HIV-related cancer
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.